Spinal Fusions Ineffective for Vertebral Fracture Pain
|
By HospiMedica International staff writers Posted on 05 Feb 2019 |
Vertebral augmentation procedures such as vertebroplasty and balloon kyphoplasty do not promote pain relief following vertebral fracture (VF), claims a new study.
Researchers at Monash University (Melbourne, Australia), Beth Israel Deaconess Medical Center (Boston, MA, USA), the University of Sheffield (United Kingdom), and other institutions conducted a systematic literature review and meta‐analysis of studies in order to address what is currently known (and not known) on the safety and efficacy of vertebral augmentation, including reviewing available evidence to assess if VF risk is increased following the procedure.
The review found that vertebroplasty did not provide significantly better pain control than placebo in five randomized placebo-controlled trials, but there was weak evidence of the benefit of kyphoplasty in one clinical trial when compared to nonsurgical management. Potential harms from vertebroplasty and balloon kyphoplasty, on the other hand, included cement leakage, adjacent fractures, and more serious adverse events. The evidence was unclear if these procedures increased the risk of VF or related serious adverse events.
The review also found no evidence that spinal bracing reduced pain immediately after VF, although low-quality evidence suggested that wearing a brace for two hours a day over six months might help. Neither was there was evidence that exercise may improve mobility, alleviate pain, and reduce fear of falling. The researchers did mention the critical importance of anti-osteoporotic medications, which can reduce the risk of subsequent vertebral fractures by 40-70%. The study was published on January 24, 2019, in the Journal of Bone and Mineral Research.
“The message for doctors and their patients suffering from painful spinal fractures is that procedures to stabilize spinal fractures should not be a first choice for treatment. We found no significant benefit over the long-term in improving pain, back-related disability, and quality of life when compared with those who did not have the procedures,” concluded lead author Peter Ebeling, MBBS, of Monash University, and colleagues. “This is a painful condition that for most people spontaneously gets better with time, and can be managed with analgesic medications over the short-term.”
Osteoporotic compression fractures of the vertebral body can result in pain and long-term morbidity, including spinal deformity. Conservative management includes opioids and other analgesics, bed rest, and a back brace. Surgical options include vertebroplasty, in which polymethylmethacrylate is injected into the fractured vertebral body; and balloon kyphoplasty, which uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore it to a more normal shape before cement injection.
Related Links:
Monash University
Beth Israel Deaconess Medical Center
University of Sheffield
Researchers at Monash University (Melbourne, Australia), Beth Israel Deaconess Medical Center (Boston, MA, USA), the University of Sheffield (United Kingdom), and other institutions conducted a systematic literature review and meta‐analysis of studies in order to address what is currently known (and not known) on the safety and efficacy of vertebral augmentation, including reviewing available evidence to assess if VF risk is increased following the procedure.
The review found that vertebroplasty did not provide significantly better pain control than placebo in five randomized placebo-controlled trials, but there was weak evidence of the benefit of kyphoplasty in one clinical trial when compared to nonsurgical management. Potential harms from vertebroplasty and balloon kyphoplasty, on the other hand, included cement leakage, adjacent fractures, and more serious adverse events. The evidence was unclear if these procedures increased the risk of VF or related serious adverse events.
The review also found no evidence that spinal bracing reduced pain immediately after VF, although low-quality evidence suggested that wearing a brace for two hours a day over six months might help. Neither was there was evidence that exercise may improve mobility, alleviate pain, and reduce fear of falling. The researchers did mention the critical importance of anti-osteoporotic medications, which can reduce the risk of subsequent vertebral fractures by 40-70%. The study was published on January 24, 2019, in the Journal of Bone and Mineral Research.
“The message for doctors and their patients suffering from painful spinal fractures is that procedures to stabilize spinal fractures should not be a first choice for treatment. We found no significant benefit over the long-term in improving pain, back-related disability, and quality of life when compared with those who did not have the procedures,” concluded lead author Peter Ebeling, MBBS, of Monash University, and colleagues. “This is a painful condition that for most people spontaneously gets better with time, and can be managed with analgesic medications over the short-term.”
Osteoporotic compression fractures of the vertebral body can result in pain and long-term morbidity, including spinal deformity. Conservative management includes opioids and other analgesics, bed rest, and a back brace. Surgical options include vertebroplasty, in which polymethylmethacrylate is injected into the fractured vertebral body; and balloon kyphoplasty, which uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore it to a more normal shape before cement injection.
Related Links:
Monash University
Beth Israel Deaconess Medical Center
University of Sheffield
Latest Critical Care News
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
- Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
- AI Expands Across Heart Failure Care Continuum to Improve Management
- Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
- Microneedle Sensor Enables Continuous Monitoring of Drug Clearance
- 3D Brain Imaging Marker Predicts Surgical Outcomes in Dementia-Causing Hydrocephalus
- Printed Artificial Neurons Stimulate Natural Brain Circuits
- Review Advances Precision Care Pathway for Meningioma Management
- Synthetic Biology Approach Enables On-Demand Liver Tissue Growth
- Bioinspired Imaging System Identifies Cancerous Lymph Nodes Intraoperatively
- Portable AI Device Enables Low-Cost Screening for Anterior Eye Diseases
- FDA-Cleared ECG Software Powers Real-Time Cardiac Monitoring at Scale
- Collaboration Brings Continuous Monitoring to Metabolic Care Management
- Low-Frequency Wireless Sensor Monitors Arterial Stiffening and Blood Pressure
- FDA-Cleared Transseptal Access Device Enables Site-Specific Left Atrial Puncture
- AI Tool Estimates CPAP Effect on Cardiovascular Risk in Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreSurgical Techniques
view channel
Early “Heart Training” Surgery Promotes Regeneration in Pediatric Heart Failure
Dilated cardiomyopathy, an enlargement of the heart muscle that weakens systolic function, leaves critically ill children with few effective therapies. Clinicians must often bridge prolonged heart failure... Read moreCE-Marked Stapler Designed to Improve Staple Line Integrity
Leaks and bleeding around stapled transections remain key drivers of morbidity and reintervention in gastrointestinal and thoracic surgery, prompting surgeons to reinforce staple lines to mitigate risk.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channelBusiness
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more







